Patent ID: 8957113
Filing Date: 2015-02-17
Classification: A61K,A61P

Abstract:
1. An oral dosage form comprising tranexamic acid or a pharmaceutically acceptable salt thereof, present in an amount that provides a dose of about 650 mg of tranexamic acid, and a pharmaceutically acceptable excipient; said dosage form providing an in-vitro dissolution release rate of the tranexamic acid or pharmaceutically acceptable salt thereof, when measured by a USP 27 Apparatus Type II Paddle Method@50 RPM in 900 ml water at 37±0.5° C., wherein from about 0% to 95% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof is released by about 15 minutes; from about 30% to about 95% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof is released by about 30 minutes; from about 70% to about 95% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof is released by about 45 minutes; and about 100% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof is released at about 60 minutes.